Podme logo
HjemOppdagKategorierSøkStudent
Investing in Biotech

Investing in Biotech

27:312021-08-13

Om episode

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Scott Power of Morgans and Jon Pilcher, CEO of Neuren Pharmaceuticals.

Nyeste episoder

Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-2237min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-011h 2min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-03-2149min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-02-1034min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-12-2231min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-11-0842min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-10-2635min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

BioBullets: The Great Dispersion

2021-09-1713min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-09-1337min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

BioBullets: The Aduhelm FDA approval controversy

2021-08-1310min
logo

PODME

INFORMASJON

  • Om informasjonskapsler
  • Generelle vilkår
  • Personvernerklæring

LAST NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag
redaktorsansvar

Podme arbeider etter Vær Varsom-plakatens regler for god presseskikk. Ansvarlig redaktør og daglig leder er Kristin Ward Heimdal. Redaktør for eksterne innholdssamarbeid er Mathias Thaulow Lisberg.

© Podme AB 2024